BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30947871)

  • 1. Hepatic Complications of Inflammatory Bowel Disease.
    Mahfouz M; Martin P; Carrion AF
    Clin Liver Dis; 2019 May; 23(2):191-208. PubMed ID: 30947871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
    Rojas-Feria M; Castro M; Suárez E; Ampuero J; Romero-Gómez M
    World J Gastroenterol; 2013 Nov; 19(42):7327-40. PubMed ID: 24259964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerosing Cholangitis in Children and Adolescents.
    Mieli-Vergani G; Vergani D
    Clin Liver Dis; 2016 Feb; 20(1):99-111. PubMed ID: 26593293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatobiliary disease in inflammatory bowel disease.
    Ahmad J; Slivka A
    Gastroenterol Clin North Am; 2002 Mar; 31(1):329-45. PubMed ID: 12122741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks.
    Massironi S; Pirola L; Mulinacci G; Ciaccio A; Viganò C; Palermo A; Zilli A; Invernizzi P; Danese S
    Inflamm Bowel Dis; 2023 Sep; 29(9):1477-1487. PubMed ID: 36040402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The liver in pediatric gastrointestinal disease.
    Vo HD; Xu J; Rabinowitz SS; Fisher SE; Schwarz SM
    J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):288-99. PubMed ID: 25144777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatotoxicity of agents used in the management of inflammatory bowel disease.
    Khokhar OS; Lewis JH
    Dig Dis; 2010; 28(3):508-18. PubMed ID: 20926880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatobiliary Manifestation of Inflammatory Bowel Disease].
    Seo KI; Kang SB
    Korean J Gastroenterol; 2019 May; 73(5):248-259. PubMed ID: 31132831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary sclerosing cholangitis: a clinical update.
    Williamson KD; Chapman RW
    Br Med Bull; 2015 Jun; 114(1):53-64. PubMed ID: 25981516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatobiliary manifestations in inflammatory bowel disease].
    Solís Herruzo JA; Solís-Muñoz P
    Rev Esp Enferm Dig; 2007 Sep; 99(9):525-42. PubMed ID: 18052648
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on primary sclerosing cholangitis.
    Karlsen TH; Boberg KM
    J Hepatol; 2013 Sep; 59(3):571-82. PubMed ID: 23603668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study.
    Fousekis FS; Katsanos KH; Theopistos VI; Baltayiannis G; Kosmidou M; Glantzounis G; Christou L; Tsianos EV; Christodoulou DK
    BMC Gastroenterol; 2019 Apr; 19(1):48. PubMed ID: 30943899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.
    DeFilippis EM; Kumar S
    Dig Dis Sci; 2015 Oct; 60(10):2873-80. PubMed ID: 25999245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing abnormal liver tests in children with inflammatory bowel disease.
    van Rheenen PF
    Curr Opin Pediatr; 2021 Oct; 33(5):521-529. PubMed ID: 34261897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.
    Navaneethan U; Shen B
    Inflamm Bowel Dis; 2010 Sep; 16(9):1598-619. PubMed ID: 20198712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatobiliary complications of inflammatory bowel disease: overview of the issues.
    Balistreri WF
    Inflamm Bowel Dis; 1998 Aug; 4(3):220-4. PubMed ID: 9741026
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoimmune sequential overlap syndrome (autoimmune hepatitis/primary sclerosing cholangitis) and inflammatory bowel disease: three clinical cases.
    Núñez Figueroa P; Sedano Muñoz R; Quera Pino R; Carrasco-Avino G; O Brien A; Brahm Barril J
    Rev Esp Enferm Dig; 2020 Oct; 112(10):788-791. PubMed ID: 32954772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic manifestations of inflammatory bowel diseases.
    Restellini S; Chazouillères O; Frossard JL
    Liver Int; 2017 Apr; 37(4):475-489. PubMed ID: 27712010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatobiliary manifestations of inflammatory bowel disease.
    Raj V; Lichtenstein DR
    Gastroenterol Clin North Am; 1999 Jun; 28(2):491-513. PubMed ID: 10372279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatobiliary associations with inflammatory bowel disease.
    Knight C; Murray KF
    Expert Rev Gastroenterol Hepatol; 2009 Dec; 3(6):681-91. PubMed ID: 19929587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.